Company profile: ImmunoVision
1.1 - Company Overview
Company description
- Provider of proprietary diagnostic reagents and test kits, specializing in their manufacture and marketing.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ImmunoVision
BIA Separations
HQ: Slovenia
Website
- Description: Provider of proprietary monolithic chromatography columns based on CIM Convective Interaction Media technology for production, purification, and analysis of large biomolecules, including viruses, plasmid DNA, exosomes, antibodies, bacteriophages, and large proteins. Offers CIMmultus preparative and CIMac analytical columns, PATfix analytical standards, and Cornerstone services and process development support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BIA Separations company profile →
CC Bio
HQ: United Kingdom
Website
- Description: Provider of microbiome-focused therapeutic discovery for diagnosis and treatment. Products include Zeus, a platform to evaluate and optimize therapeutics for precise augmentation of microbial ecology; Athena, a platform developing genetic components for biosensor circuits that sense microbiome diseases; and Dionysus, a program engineering bacterial chassis to sense metabolic changes and record information across human tissues.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CC Bio company profile →
Biosynthetic Technologies
HQ: United States
Website
- Description: Provider of biobased synthetic molecules and oils made from organic fatty acids found in plant oils for lubricant, chemical, and cosmetics applications. Products include Estolides and BioEstolides, sustainable industrial lubricant base oils, metalworking fluid additives, hydraulic oils, and personal care ingredients offering stability, lubricity, wear protection, and biodegradability.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biosynthetic Technologies company profile →
List Labs
HQ: United States
Website
- Description: Provider of microbial CDMO services, offering end-to-end support from early-stage process development to cGMP manufacturing for Phase I & II clinical supply, and research reagents including nearly 100 bacterial toxins, polysaccharides, and antibodies. Also supplies anthrax (PA, EF, LF), botulinum, C. difficile (Toxin A/B), and cholera toxins, and specializes in native toxins, recombinant proteins, fermentation, and assay development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full List Labs company profile →
Rebus Biosystems
HQ: United States
Website
- Description: Provider of spatial omics tools: Rebus Esper for single-cell data at subcellular resolution; Esper High Fidelity assay for spatial transcriptomics (up to 30 custom genes without barcoding or enzymatic amplification); Esper High Plex assay enabling analysis of 1230 gene panels; SAO microscopy enhancing resolution without sacrificing throughput; plus the Esper Service Program providing processed gene images and a spatially annotated CellxFeature matrix.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rebus Biosystems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ImmunoVision
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ImmunoVision
2.2 - Growth funds investing in similar companies to ImmunoVision
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ImmunoVision
4.2 - Public trading comparable groups for ImmunoVision
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →